Catalyst Event
Pacific Biosciences of California Inc (PACB) · Earnings Release
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
5/7/2026, 12:00:00 AM
On May 7, 2026, the company reported Q1 2026 financial results, with revenue of $37.2 million missing analyst expectations, while the non-GAAP loss per share of $0.12 was better than forecast. Following the release, the stock price declined by approximately 15%. The company also narrowed its full-year 2026 revenue guidance to a range of $165 million to $175 million.
Korean Translation
2026년 5월 7일, 2026년 1분기 실적을 발표함. 매출은 3,720만 달러로 시장 예상치를 하회했으나, 비일반회계기준(Non-GAAP) 주당순손실은 0.12달러로 예상보다 양호했음. 실적 발표 후 주가는 약 15% 하락했으며, 회사는 2026년 연간 매출 가이던스를 1억 6,500만 달러에서 1억 7,500만 달러로 하향 조정함.
Related Recent Events
JD Health International Inc (6618) · Earnings Release
Low importance estimated as no market reaction has occurred yet; Q2 2026 earnings report scheduled.
8/12/2026, 12:00:00 AM
Livzon Pharmaceutical Group Inc (1513) · Other
Ex-dividend date on June 16, 2026, for the final dividend of RMB 1.43 per 10 shares, scheduled to be paid on July 13, 2026. Low importance estimated as the dividend amount is within historical norms, scheduled.
6/16/2026, 12:00:00 AM
Grand Pharmaceutical Group Ltd (512) · Other
Ex-dividend date (2026-06-12) for the proposed 2025 final dividend of HK$0.169 per share is scheduled.
6/12/2026, 12:00:00 AM
Veracyte Inc (VCYT) · Other
Annual Meeting of Stockholders on 2026-06-10, with proposals including the election of directors and an expansion of the 2023 Equity Incentive Plan scheduled.
6/10/2026, 12:00:00 AM
Innovent Biologics Inc (1801) · Other
Innovent will present obesity pipeline data at the ADA Scientific Sessions on June 5-8, 2026; this low-impact event is scheduled
6/5/2026, 12:00:00 AM
Pacific Biosciences of California Inc (PACB) · Other
The 2026 Annual Meeting of Stockholders is scheduled for June 3, 2026, including a proposal to increase the number of shares reserved for the 2020 Equity Incentive Plan by 16,000,000. A low impact is estimated due to potential share dilution, scheduled.
6/3/2026, 12:00:00 AM